Recital 11, Regulation (EU) 2024/996

In forcesince 3 Apr 2024

In light of concerns related to potential endocrine disrupting properties of ‘4-Methylbenzylidene Camphor’, ‘Genistein’, ‘Daidzein’, ‘Kojic Acid’, ‘Triclosan’ and ‘Triclocarban’, the Commission launched a public call for data in 2019. The industry submitted scientific evidence to demonstrate the safety of those substances when used in cosmetic products. The Commission requested the SCCS to carry out a safety assessment of those substances in view of the information provided by the industry.